Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-055353

SVP & Chief Medical Officer sold 100,000 shares at an average $24.14 ($2,413,640)

  • SVP & Chief Medical Officer acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gergel Ivan P. · SVP & Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-09-29 Exercise or conversion : show line 1 in the form +43,296 $11.04 $477,988 84,871 D
2017-09-29 Sale : show line 2 in the form −43,296 $24.04 $1,040,836 41,575 D
2017-10-02 Exercise or conversion : show line 3 in the form +56,704 $11.04 $626,012 98,279 D
2017-10-02 Sale : show line 4 in the form −56,704 $24.21 $1,372,804 41,575 D
Open-market sales · 100,000 sh · avg $24.14 · $2,413,640

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-09-29 Exercise or conversion : show line 5 in the form Stock Option −43,296 370,456 D
2017-10-02 Exercise or conversion : show line 6 in the form Stock Option −56,704 313,752 D
Loading xslF345X03/doc4.xml…